Health authorities in the U.S. are continuing their move away from animal testing in drug development, with the FDA signaling ...

The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t ...

Add Yahoo as a preferred source to see more of our stories on Google. FDA Commissioner Martin Makary on Thursday announced a move away from animal-based drug testing in favor of human-based methods ...

In April 2025, the FDA announced plans to shift biomedical research for monoclonal antibodies and other medications away from ...

Federal regulators in the United States are pushing harder than ever to reduce and eventually replace animal testing in drug ...

Discover the MHRA's commitment to phasing out animal testing in the UK and adopting innovative alternatives for drug safety ...

Britain's medicines regulator said on Wednesday it will introduce a framework by the end of ​2026, which would allow ...

(Reuters) -Drug developers are increasing adoption of AI technologies for discovery and safety testing to get faster and cheaper results, in line with an FDA push to reduce animal testing in the near ...

The FDA’s recent announcement to reduce, and in some cases replace, animal testing for monoclonal antibodies and other ...

Animal testing in Connecticut rakes in millions in federal dollars each year at colleges and universities but, the National Institutes of Health recently announced it is pivoting from using just ...

Add Yahoo as a preferred source to see more of our stories on Google. Martin Makary, President Donald Trump's nominee to lead the Food and Drug Administration testifies during his confirmation hearing ...

Today’s animal testing differs from how it was back in the day. It’s typically done on a specific ingredient rather than a finished product, and there are often regulatory requirements based on ...